Yuji Kazuta

460 total citations
19 papers, 396 citations indexed

About

Yuji Kazuta is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Yuji Kazuta has authored 19 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Organic Chemistry, 6 papers in Molecular Biology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Yuji Kazuta's work include Cyclopropane Reaction Mechanisms (8 papers), Asymmetric Synthesis and Catalysis (7 papers) and Synthetic Organic Chemistry Methods (5 papers). Yuji Kazuta is often cited by papers focused on Cyclopropane Reaction Mechanisms (8 papers), Asymmetric Synthesis and Catalysis (7 papers) and Synthetic Organic Chemistry Methods (5 papers). Yuji Kazuta collaborates with scholars based in Japan and United States. Yuji Kazuta's co-authors include Satoshi Shuto, Akira Matsuda, Shizuo Yamada, Hiroshi Abe, Kazuya Yamaguchi, Tamotsu Yamamoto, Kazufumi Hirano, Hideki Hayashi, Mizuki Watanabe and Shun‐ichiro Matsumoto and has published in prestigious journals such as The Journal of Physical Chemistry B, FEBS Letters and Journal of Medicinal Chemistry.

In The Last Decade

Yuji Kazuta

18 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yuji Kazuta Japan	12	276	163	46	29	22	19	396
Paul S. Humphries United States	11	172 0.6×	152 0.9×	20 0.4×	36 1.2×	22 1.0×	21	369
Karin Briner United States	14	489 1.8×	370 2.3×	10 0.2×	38 1.3×	28 1.3×	28	650
George D. Maynard United States	13	237 0.9×	113 0.7×	21 0.5×	89 3.1×	11 0.5×	25	451
Yuko Mitobe Japan	10	167 0.6×	142 0.9×	57 1.2×	50 1.7×	5 0.2×	24	331
Adam J. Davenport United Kingdom	10	268 1.0×	157 1.0×	114 2.5×	23 0.8×	34 1.5×	13	491
Christelle Doebelin United States	10	141 0.5×	129 0.8×	85 1.8×	26 0.9×	20 0.9×	19	382
Doris Riether United States	13	153 0.6×	219 1.3×	10 0.2×	80 2.8×	26 1.2×	24	419
Giles A. Brown United Kingdom	13	173 0.6×	241 1.5×	12 0.3×	122 4.2×	13 0.6×	17	455
Linus S. Lin United States	13	189 0.7×	157 1.0×	20 0.4×	82 2.8×	16 0.7×	20	401
Daniel H. Caignard France	15	321 1.2×	199 1.2×	7 0.2×	58 2.0×	14 0.6×	31	517

Countries citing papers authored by Yuji Kazuta

Since Specialization

Citations

This map shows the geographic impact of Yuji Kazuta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuji Kazuta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuji Kazuta more than expected).

Fields of papers citing papers by Yuji Kazuta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuji Kazuta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuji Kazuta. The network helps show where Yuji Kazuta may publish in the future.

Co-authorship network of co-authors of Yuji Kazuta

This figure shows the co-authorship network connecting the top 25 collaborators of Yuji Kazuta. A scholar is included among the top collaborators of Yuji Kazuta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuji Kazuta. Yuji Kazuta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Fukushima, Kazuyuki, Hiroyuki Higashiyama, Yuji Kazuta, et al.. (2023). Discovery ofE2730, a novel selective uncompetitiveGAT1inhibitor, as a candidate for anti‐seizure medication. Epilepsia Open. 8(3). 834–845. 5 indexed citations

Uno, Shin‐nosuke, Yuji Kazuta, Yuki Shimaoka, et al.. (2021). Silinanyl Rhodamines and Silinanyl Fluoresceins for Super-Resolution Microscopy. The Journal of Physical Chemistry B. 125(31). 8703–8711. 14 indexed citations

Nishikawa, Youichi, et al.. (2020). An orange-fluorescent dye with long-lasting blinking for single molecule localization microscopy. 15–15.

Yoshida, Yu, Yuji Kazuta, Carsten T. Beuckmann, et al.. (2014). Design, synthesis, and structure–activity relationships of a series of novel N-aryl-2-phenylcyclopropanecarboxamide that are potent and orally active orexin receptor antagonists. Bioorganic & Medicinal Chemistry. 22(21). 6071–6088. 20 indexed citations

Yamaguchi, Kazuya, Yuji Kazuta, Kazufumi Hirano, et al.. (2008). Synthesis of 1-arylpiperazyl-2-phenylcyclopropanes designed as antidopaminergic agents: Cyclopropane-based conformationally restricted analogs of haloperidol. Bioorganic & Medicinal Chemistry. 16(19). 8875–8881. 17 indexed citations

Watanabe, Mizuki, Yuji Kazuta, Hideki Hayashi, et al.. (2006). Stereochemical Diversity-Oriented Conformational Restriction Strategy. Development of Potent Histamine H ₃ and/or H ₄ Receptor Antagonists with an Imidazolylcyclopropane Structure. Journal of Medicinal Chemistry. 49(18). 5587–5596. 52 indexed citations

Watanabe, Mizuki, Yuji Kazuta, Hideki Hayashi, et al.. (2006). P-253 DEVELOPMENT OF POTENT HISTAMINE H_3 AND/OR H_4 RECEPTOR ANTAGONISTS BY THE STEREOCHEMICAL DIVERSITY-ORIENTED CONFORMATIONAL RESTRICTION STRATEGY. 2006. 1 indexed citations

Kazuta, Yuji, Hiroshi Abe, Akira Matsuda, & Satoshi Shuto. (2004). Highly Stereoselective Grignard Addition to Cis-Substituted C-Cyclopropylaldonitrones. The Bisected s-Trans Transition State Can Be Stabilized Effectively by the Lewis Acid-Coordination. The Journal of Organic Chemistry. 69(26). 9143–9150. 10 indexed citations

Kazuta, Yuji, Hiroshi Abe, Tamotsu Yamamoto, Akira Matsuda, & Satoshi Shuto. (2004). The unusual 1,4-chelation-controlled nucleophilic addition to aldehydes with high stereoselectivity. A systematic study of stereoselectivity in the addition reaction of carbon nucleophiles to cis-substituted cyclopropanecarbaldehydes. Tetrahedron. 60(31). 6689–6703. 12 indexed citations

10.

Kazuta, Yuji, Kazufumi Hirano, Shizuo Yamada, et al.. (2003). Cyclopropane-Based Conformational Restriction of Histamine. (1S,2S)-2-(2-Aminoethyl)-1-(1H-imidazol-4-yl)cyclopropane, a Highly Selective Agonist for the Histamine H₃ Receptor, Having a cis-Cyclopropane Structure. Journal of Medicinal Chemistry. 46(10). 1980–1988. 64 indexed citations

11.

Kazuta, Yuji, Hiroshi Abe, Tamotsu Yamamoto, Akira Matsuda, & Satoshi Shuto. (2003). A Systematic Study of the Hydride Reduction of Cyclopropyl Ketones with Structurally Simplified Substrates. Highly Stereoselective Reductions ofTrans-Substituted Cyclopropyl Ketones via the Bisecteds-CisConformation. The Journal of Organic Chemistry. 68(9). 3511–3521. 27 indexed citations

12.

Yamaguchi, Kazuya, Yuji Kazuta, Hiroshi Abe, Akira Matsuda, & Satoshi Shuto. (2003). Construction of a cis-Cyclopropane via Reductive Radical Decarboxylation. Enantioselective Synthesis of cis- and trans-1-Arylpiperazyl-2-phenylcyclopropanes Designed as Antidopaminergic Agents. The Journal of Organic Chemistry. 68(24). 9255–9262. 39 indexed citations

13.

Kazuta, Yuji, Ryuichi Tsujita, Shigeo Uchino, et al.. (2002). Synthesis of derivatives of (1S,2R)-1-phenyl-2-[(S)-1-aminopropyl]-N,N-diethylcyclopropanecarboxamide (PPDC) modified at the 1-aromatic moiety as novel NMDA receptor antagonists: the aromatic group is essential for the activity. Bioorganic & Medicinal Chemistry. 10(12). 3829–3848. 18 indexed citations

14.

Kazuta, Yuji, Ryuichi Tsujita, Shigeo Uchino, et al.. (2002). Synthesis of (1S,2R)-1-phenyl-2-[(S)-1-aminoalkyl]-N,N-diethylcyclopropanecarboxamides as novel NMDA receptor antagonists having a unique NMDA receptor subtype selectivity. Journal of the Chemical Society Perkin Transactions 1. 1199–1212. 6 indexed citations

15.

OGAWA, Kiyoshi, et al.. (2002). Conformational Analysis of the NMDA Receptor Antagonist (1S,2R)-1-Phenyl-2-[(S)-1-aminopropyl]-N,N-diethylcyclopropanecarboxamide (PPDC) Designed by a Novel Conformational Restriction Method Based on the Structural Feature of Cyclopropane Ring.. Chemical and Pharmaceutical Bulletin. 50(7). 966–968. 13 indexed citations

16.

Kazuta, Yuji, Akira Matsuda, & Satoshi Shuto. (2002). Development of Versatile cis- and trans-Dicarbon-Substituted Chiral Cyclopropane Units: Synthesis of (1S,2R)- and (1R,2R)-2-Aminomethyl-1-(1H-imidazol-4-yl)cyclopropanes and Their Enantiomers as Conformationally Restricted Analogues of Histamine. The Journal of Organic Chemistry. 67(5). 1669–1677. 74 indexed citations

17.

Uchino, Shigeo, Wakako Watanabe, Takeshi Nakamura, et al.. (2001). Establishment of CHO cell lines expressing four N‐methyl‐D‐aspartate receptor subtypes and characterization of a novel antagonist PPDC. FEBS Letters. 506(2). 117–122. 8 indexed citations

18.

Kazuta, Yuji, Satoshi Shuto, Hiroshi Abe, & Akira Matsuda. (2001). The bisected s-trans conformation-controlled highly stereoselective addition of Grignard reagents to C-cyclopropylaldonitrone. An efficient synthesis of 1-phenyl-2-[(S )-1-aminoalkyl]-N,N-diethylcyclopropanecarboxamides, a new class of potent NMDA receptor antagonists. Journal of the Chemical Society Perkin Transactions 1. 599–604. 4 indexed citations

19.

Kazuta, Yuji, Satoshi Shuto, & Akira Matsuda. (2000). Highly stereoselective addition of Grignard reagents to C-cyclopropylnitrone via the bisected s-trans conformation. An efficient synthesis of PEDC, a potent NMDA receptor antagonist having a cyclopropane structure. Tetrahedron Letters. 41(28). 5373–5377. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact